rdf:type |
|
lifeskim:mentions |
umls-concept:C0015450,
umls-concept:C0020269,
umls-concept:C0027530,
umls-concept:C0042900,
umls-concept:C0063080,
umls-concept:C0087111,
umls-concept:C0205195,
umls-concept:C0282440,
umls-concept:C0392265,
umls-concept:C1096777,
umls-concept:C1280519,
umls-concept:C1378128
|
pubmed:issue |
5
|
pubmed:dateCreated |
2008-11-27
|
pubmed:abstractText |
Vitiligo is a pigmentary disorder which may have disfiguring consequences. Its treatment remains a challenge.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1365-2133
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
159
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1186-91
|
pubmed:meshHeading |
pubmed-meshheading:18717675-Administration, Topical,
pubmed-meshheading:18717675-Adolescent,
pubmed-meshheading:18717675-Adult,
pubmed-meshheading:18717675-Aged,
pubmed-meshheading:18717675-Combined Modality Therapy,
pubmed-meshheading:18717675-Dermatologic Agents,
pubmed-meshheading:18717675-Facial Dermatoses,
pubmed-meshheading:18717675-Female,
pubmed-meshheading:18717675-Humans,
pubmed-meshheading:18717675-Hydrocortisone,
pubmed-meshheading:18717675-Lasers, Excimer,
pubmed-meshheading:18717675-Male,
pubmed-meshheading:18717675-Middle Aged,
pubmed-meshheading:18717675-Neck,
pubmed-meshheading:18717675-Quality of Life,
pubmed-meshheading:18717675-Treatment Outcome,
pubmed-meshheading:18717675-Vitiligo,
pubmed-meshheading:18717675-Young Adult
|
pubmed:year |
2008
|
pubmed:articleTitle |
Randomized controlled trial comparing the effectiveness of 308-nm excimer laser alone or in combination with topical hydrocortisone 17-butyrate cream in the treatment of vitiligo of the face and neck.
|
pubmed:affiliation |
Centro Studi GISED, Ospedali, Riuniti, 24100 Bergamo, Italy.
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|